Ana María A. P.
- Country
- Spain
- Department
- Farmacología Clínica
Research Overview
- Physiologically Based Pharmacokinetic Modeling of Oral and Intranasal Zolmitriptan Formulations in Healthy Volunteers
- Phase I Study on the Safety and Tolerability of RA0127 for the Prevention of Gram-negative Bacterial Infections in Healthy Volunteers
- Pharmacokinetic and safety assessment of substances prohibited by the World Anti-Doping Agency in healthy volunteers: A proof-of-concept study
Data & Insights
Has run more than one trial at 10 of 15 partner sites.
Specializations
Pain Management & Analgesia
This investigator conducts research in acute pain management, with particular focus on dental pain control and the evaluation of combination analgesic therapies.
- Post-surgical dental pain
- Moderate to severe pain treatment
- Combination analgesic therapy
Ophthalmology
The investigator specializes in age-related macular degeneration treatment research, focusing on evaluating therapeutic responses and genetic factors.
- Anti-VEGF therapy evaluation
- Genetic polymorphism studies
- Comparative treatment efficacy
Allergic Conditions
Research expertise extends to allergic disorders and their treatments, including studies of antihistamine medications in various patient populations.
- Allergic rhinitis
- Chronic urticaria
- Allergic asthma management
Clinical Pharmacology
The investigator conducts pharmacokinetic modeling studies across various drug delivery routes and evaluates medication safety in special populations.
- Drug absorption studies
- Hepatic impairment effects
- Renal function impact
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.